2026-05-14 01:15:50
Latest Post
Cybertech Systems and Software Ltd Q4 FY2025-26 consolidated net profit at Rs. 7.06 crores
JSW Dulux Ltd Q4 FY2026 consolidated PAT rises to Rs. 125.7 crores
LIC Housing Finance Ltd Q4 FY2026 consolidated PAT up at Rs. 1492.54 crores
Nitco Ltd Q4 FY26 consolidated loss at Rs. 7.78 crore
Chemfab Alkalis Ltd Q4FY26 consolidated profit at Rs. 48.46 lakhs
Stock Report
OneSource Specialty Pharma Ltd consolidated Q4 FY2026 profit at Rs. 4.59 crores
Posted On : 2026-05-13 22:26:45( TIMEZONE : IST )
Onesource Specialty Pharma Limited has reported Consolidated financial results for the period ended March 31, 2026.
Financial Results (Q4 FY2026) - QoQ Comparison
The company has reported total income of Rs. 430.310 crores during the period ended March 31, 2026 as compared to Rs. 294.965 crores during the period ended December 31, 2025.
The company has posted net profit / (loss) of Rs. 4.597 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. -88.699 crores for the period ended December 31, 2025.
The company has reported EPS of Rs. 0.40 for the period ended March 31, 2026 as compared to Rs. -7.74 for the period ended December 31, 2025.
| Financials | Q4 FY2026 | Q3 FY2026 | % Change |
| Total Income | ₹ 430.310 crs | ₹294.965 crs |  45.89% |
| Net Profit | ₹4.597 crs | ₹-88.699 crs | 105.18% |
| EPS | ₹0.40 | ₹-7.74 | 105.17% |
Financial Results (Q4 FY2026) - YoY Comparison
The company has reported total income of Rs. 430.310 crores during the period ended March 31, 2026 as compared to Rs.428.843 crores during the period ended March 31, 2025.
The company has posted net profit / (loss) of Rs.4.597 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.98.502 crores for the period ended March 31, 2025.
The company has reported EPS of Rs.0.40 for the period ended March 31, 2026 as compared to Rs.8.59 for the period ended March 31, 2025.
| Financials | Q4 FY2026 | Q4 FY2025 | % Change |
| Total Income | ₹ 430.310 crs | ₹428.843 crs | 0.34% |
| Net Profit | ₹4.597 crs | ₹98.502 crs |  -95.33% |
| EPS | ₹0.40 | ₹8.59 | -95.34% |
Financial Results (Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.1436.612 crores during the Financial Year ended March 31, 2026 as compared to Rs.1462.327 crores during the Financial Year ended March 31, 2025.
The company has posted net profit / (loss) of Rs.-73.803 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.-17.971 crores for the Financial Year ended March 31, 2025.
The company has reported EPS of Rs.-6.44 for the Financial Year ended March 31, 2026 as compared to Rs.-1.63 for the Financial Year ended March 31, 2025.
| Financials | Year Ended FY2026 | Year Ended FY2025 | % Change |
| Total Income | ₹1436.612 crs | ₹1462.327 crs | -1.76% |
| Net Profit | ₹-73.803 crs | ₹-17.971 crs |  310.68% |
| EPS | ₹-6.44 | ₹-1.63 | 295.09% |
Shares of Onesource Specialty Pharma Limited was last trading in BSE at Rs. 1790.65 as compared to the previous close of Rs. 1833.55. The total number of shares traded during the day was 24660 in over 4343 trades.
The stock hit an intraday high of Rs. 1832.00 and intraday low of 1733.30. The net turnover during the day was Rs. 43950849.00.
